Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-12Clinical Trial Update: The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease" [Phase 3]
A Phase 3 trial of Pentasa Sachet (mesalamine) for mucosal healing in mild-to-moderate Crohn's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's Disease [Phase 3]
Phase 3 clinical trial evaluating VSL#3 probiotic plus infliximab in children with Crohn's disease; the current study status is unknown.
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease [Phase 2]
A Phase 2 trial of visilizumab for moderate to severe inflammatory, nonstricturing Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Visilizumab for Treatment of Perianal Fistulas in Crohn's Disease [Phase 2]
This is a completed Phase 2 clinical trial evaluating visilizumab for treatment of perianal fistulas in Crohn's disease.
-
CLINICAL_TRIALS trial_result · 2012-02-24Clinical Trial Update: Efficacy and Safety Study of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's Disease [Phase 2]
Phase 2 study evaluating D9421-C at 9 mg and 15 mg versus placebo in Japanese patients with active Crohn's disease; efficacy and safety resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: Vitamin D in Pediatric Crohn's Disease [Phase 4]
Phase 4 trial evaluating Vitamin D supplementation in pediatric Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED)
This entry reports the completion of Crohn's disease study P03288 for Remicade (infliximab), with results posted in February 2012.
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Allogenic Stem Cells Derived From Lipoaspirates for the Treatment of Recto-vaginal Fistulas Associated to Crohn's Disease (ALOREVA) [Phase 1, Phase 2]
Completed Phase 1/2 clinical trial evaluating allogenic stem cells derived from lipoaspirates for treating rectovaginal fistulas in Crohn's …
-
FDA approval · 2012-01-20FDA Approved: TYSABRI — Supplemental Application (Biogen Inc.)
The FDA approved Biogen Inc.'s supplemental application for TYSABRI (natalizumab). This action updates the product's labeling per the submis…
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: A Trial of Wellbutrin for Crohn's Disease [Phase 2, Phase 3]
This document reports the completion of a Phase 2/Phase 3 clinical trial evaluating Wellbutrin (bupropion) for Crohn's disease.
-
CLINICAL_TRIALS trial_result · 2012-01-16Clinical Trial Update: Centocor Microarray Study of Patients [Phase 4]
This is a Phase 4 clinical trial update (Centocor Microarray Study) that has completed with results posted; the study investigated patients …
-
CLINICAL_TRIALS research · 2012-01-02Clinical Trial Update: Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's Disease
A clinical trial update focuses on diagnostics for intestinal tuberculosis and how to differentiate it from Crohn's disease.
-
FDA approval · 2011-12-26FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA has approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
-
CLINICAL_TRIALS trial_result · 2011-12-16Clinical Trial Update: Cannabis for Inflammatory Bowel Disease [Phase 1, Phase 2]
A clinical trial update describes Phase 1/Phase 2 studies evaluating cannabis for inflammatory bowel disease, including Crohn's disease and …
-
CLINICAL_TRIALS research · 2011-12-14Clinical Trial Update: Durability and Tolerability of Infliximab in Pediatric Inflammatory Bowel Disease Patients: A 10 Year Single Center Experience
A 10-year single-center observational update evaluating the durability and tolerability of infliximab in pediatric inflammatory bowel diseas…
-
FDA approval · 2011-12-13FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for HUMIRA (adalimumab) filed by Cordavis Limited.
-
CLINICAL_TRIALS trial_result · 2011-12-12Clinical Trial Update: Prebiotic Effect on Metabolites in Crohn's Disease [NA]
A completed clinical trial evaluating the prebiotic effect on metabolites in Crohn's disease conducted by KU Leuven.
-
CLINICAL_TRIALS research · 2011-11-28Clinical Trial Update: Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy [Phase 4]
A Phase 4 clinical trial update assessing whether combining measurements of serum infliximab and anti-infliximab antibodies helps treat Croh…
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: Chromoendoscopy for Ulcerative Colitis Surveillance
A clinical trial update indicates that the chromoendoscopy surveillance study for ulcerative colitis has completed. The study included parti…
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: Program Extension of Real Life Dosing of Remicade in Austria for Crohn's Disease (Study P04052)(COMPLETED)
A completed clinical trial update reports a program extension of real-life dosing of Remicade (infliximab) in Austria for Crohn's disease, w…
-
CLINICAL_TRIALS trial_result · 2011-10-17Clinical Trial Update: CP-461 for the Treatment of Crohn's Disease [Phase 2]
Phase 2 clinical trial CP-461 for Crohn's disease conducted by Astellas Pharma has completed.
-
FDA approval · 2011-10-07FDA Approved: TYSABRI — Supplemental Application (Biogen Inc.)
The FDA approved Biogen's supplemental application for TYSABRI (natalizumab), resulting in a labeling update as part of a supplemental appro…
-
CLINICAL_TRIALS trial_result · 2011-09-21Clinical Trial Update: A Comparative Study of Capsule Endoscopy, Magnetic Resonance Imaging and Computer Tomography Scanning of the Small Bowel in Crohn's Disease [NA]
This is an update on a completed clinical trial comparing capsule endoscopy, magnetic resonance imaging, and computed tomography scanning of…
-
FDA approval · 2011-09-16FDA Approved: TYSABRI — Supplemental Application (Biogen Inc.)
The FDA approved Biogen's supplemental application for Tysabri (Natalizumab).
-
CLINICAL_TRIALS trial_result · 2011-09-16Clinical Trial Update: Trial of Growth Hormone Therapy in Pediatric Crohn's Disease [Phase 2]
Phase 2 trial update on growth hormone therapy for pediatric Crohn's disease; study completed with results posted in 2011.